Pfizer Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Mar 2026 is -2.45% vs 0.42% in Dec 2025

Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 40.88% vs -24.96% in Dec 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 3.40% vs -0.76% in Dec 2025

Interest

QoQ Growth in quarter ended Mar 2026 is 6.03% vs -6.57% in Dec 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Pfizer With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

629.23

776.25

-147.02

-18.94%

Other Operating Income

0.00

Total Operating income

629.23

776.25

-147.02

-18.94%

Raw Material Cost

83.04

230.79

-147.75

-64.02%

Purchase of Finished goods

117.69

0.00

117.69

(Increase) / Decrease In Stocks

19.63

38.50

-18.87

-49.01%

Employee Cost

77.18

95.27

-18.09

-18.99%

Power Cost

0.00

Manufacturing Expenses

0.00

51.72

-51.72

-100.00%

Selling and Distribution Expenses

0.00

Other Expenses

95.74

53.06

42.68

80.44%

Total Expenditure (Excl Depreciation)

393.28

469.34

-76.06

-16.21%

Operating Profit (PBDIT) excl Other Income

235.95

306.91

-70.96

-23.12%

Other Income

40.72

12.46

28.26

226.81%

Operating Profit (PBDIT)

276.67

319.37

-42.70

-13.37%

Interest

2.11

7.23

-5.12

-70.82%

Exceptional Items

9.04

0.00

9.04

Gross Profit (PBDT)

283.60

312.14

-28.54

-9.14%

Depreciation

14.78

25.09

-10.31

-41.09%

Profit Before Tax

268.82

287.04

-18.22

-6.35%

Tax

69.00

74.52

-5.52

-7.41%

Provisions and contingencies

0.00

Profit After Tax

199.82

212.52

-12.70

-5.98%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

199.82

212.52

-12.70

-5.98%

Equity Capital

45.75

12.90

32.85

254.65%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

43.68

164.74

-121.06

-73.49%

Diluted Earnings per share

43.68

165.65

-121.97

-73.63%

Operating Profit Margin (Excl OI)

37.50%

39.54%

0.00

-2.04%

Gross Profit Margin

45.07%

40.21%

0.00

4.86%

PAT Margin

31.76%

27.38%

0.00

4.38%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 629.23 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -2.45% vs 0.42% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 6.31% vs 8.28% in Mar 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 199.82 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 40.88% vs -24.96% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -39.62% vs 85.03% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 235.95 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 3.40% vs -0.76% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 3.71% vs 20.10% in Mar 2025

Quarterly - Interest

Interest 2.11 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 6.03% vs -6.57% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -21.56% vs -61.29% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 37.50%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025